<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35100">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01847820</url>
  </required_header>
  <id_info>
    <org_study_id>C13-ROM-001</org_study_id>
    <nct_id>NCT01847820</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the AmniSure ROM Test</brief_title>
  <official_title>Clinical Evaluation of the AmniSure ROM Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>QIAGEN Gaithersburg, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>QIAGEN Gaithersburg, Inc</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To show that having less qualified personnel (non-Laboratory trained professionals) perform
      the test yields the same result as if a Laboratory trained professional performed the test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main goal of this study is to show that when performed by less qualified personnel, the
      AmniSure® ROM Test is so simple and accurate that the likelihood of erroneous results by the
      Intended-User is negligible and that the test poses no unreasonable risk of harm to the
      patient if performed incorrectly.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>The evaluation the clinical performance of the AmniSure® ROM test performed by the Intended-User relative to the clinical diagnosis of rupture of membranes.</measure>
    <time_frame>At time of enrollment</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigational AmniSure ROM test will be compared to the three standard tests of nitrazine, ferning and pooling to determine rupture of fetal membranes.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Rupture of Fetal Membranes</condition>
  <arm_group>
    <arm_group_label>Symptomatic</arm_group_label>
    <description>Individuals with signs, symptoms or suspicion of membrane rupture at 11 to 42 weeks gestation that will receive the AmniSure ROM test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AmniSure ROM test</intervention_name>
    <description>Comparison of AmniSure ROM test to clinical diagnosis of ROM.</description>
    <arm_group_label>Symptomatic</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be women presenting with signs, symptoms or suspicion of
        membrane rupture at 11 to 42 weeks gestation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be pregnant.

          -  Subjects must be between 18 and 50 years of age and have a gestational age of
             11.0-42.0 weeks.

          -  Subjects reporting suspicion, signs, or symptoms suggestive of ROM, PROM, PPROM.

          -  Subjects providing informed consent.

        Exclusion Criteria:

          -  Subjects who have placenta previa.

          -  Subjects who have heavy vaginal bleeding.

          -  Subjects who have had digital vaginal examination immediately prior to evaluation for
             ROM.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andrew E Schumacher</last_name>
    <phone>301-944-7094</phone>
    <email>andrew.schumacher@qiagen.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California San Francisco- Fresno</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Cortez</last_name>
      <phone>559-499-6549</phone>
      <email>CCortez@fresno.ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Conrad Chao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas University Medical Center Research Institute, Inc</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Samuelson, RN, BSN</last_name>
      <phone>913-588-6287</phone>
      <email>lsamuelson@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Carl Weiner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamara D. Saunders, MA</last_name>
      <phone>843-792-6992</phone>
      <email>saundert@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Scott Sullivan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Johnson JW, Daikoku NH, Niebyl JR, Johnson TR Jr, Khouzami VA, Witter FR. Premature rupture of the membranes and prolonged latency. Obstet Gynecol. 1981 May;57(5):547-56.</citation>
    <PMID>7219903</PMID>
  </reference>
  <reference>
    <citation>LEBHERZ TB, HELLMAN LP, MADDING R, ANCTIL A, ARJE SL. DOUBLE-BLIND STUDY OF PREMATURE RUPTURE OF THE MEMBRANES. A REPORT OF 1,896 CASES. Am J Obstet Gynecol. 1963 Sep 15;87:218-25.</citation>
    <PMID>14077618</PMID>
  </reference>
  <reference>
    <citation>Gunn GC, Mishell DR Jr, Morton DG. Premature rupture of the fetal membranes. A review. Am J Obstet Gynecol. 1970 Feb 1;106(3):469-83. Review.</citation>
    <PMID>4905833</PMID>
  </reference>
  <reference>
    <citation>Sacks M, Baker TH. Spontaneous premature rupture of the membranes. A prospective study. Am J Obstet Gynecol. 1967 Apr 1;97(7):888-93.</citation>
    <PMID>6021103</PMID>
  </reference>
  <reference>
    <citation>Daikoku NH, Kaltreider DF, Khouzami VA, Spence M, Johnson JW. Premature rupture of membranes and spontaneous preterm labor: maternal endometritis risks. Obstet Gynecol. 1982 Jan;59(1):13-20.</citation>
    <PMID>7078844</PMID>
  </reference>
  <reference>
    <citation>Christensen KK, Christensen P, Ingemarsson I, Mardh PA, Nordenfelt E, Ripa T, Solum T, Svenningsen N. A study of complications in preterm deliveries after prolonged premature rupture of the membranes. Obstet Gynecol. 1976 Dec;48(6):670-7.</citation>
    <PMID>825795</PMID>
  </reference>
  <reference>
    <citation>Fayez JA, Hasan AA, Jonas HS, Miller GL. Management of premature rupture of the membranes. Obstet Gynecol. 1978 Jul;52(1):17-21.</citation>
    <PMID>683624</PMID>
  </reference>
  <reference>
    <citation>Alexander JM, Cox SM. Clinical course of premature rupture of the membranes. Semin Perinatol. 1996 Oct;20(5):369-74. Review.</citation>
    <PMID>8912990</PMID>
  </reference>
  <reference>
    <citation>ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007 Apr;109(4):1007-19.</citation>
    <PMID>17400872</PMID>
  </reference>
  <reference>
    <citation>Nisell H, Hagskog K, Westgren M. Assessment of fetal fibronectin in cervical secretion in cases of equivocal rupture of the membranes at term. Acta Obstet Gynecol Scand. 1996 Feb;75(2):132-4.</citation>
    <PMID>8604598</PMID>
  </reference>
  <reference>
    <citation>Atterbury JL, Groome LJ, Hoff C. Methods used to diagnose premature rupture of membranes: a national survey of 812 obstetric nurses. Obstet Gynecol. 1998 Sep;92(3):384-9.</citation>
    <PMID>9721775</PMID>
  </reference>
  <reference>
    <citation>de Haan HH, Offermans PM, Smits F, Schouten HJ, Peeters LL. Value of the fern test to confirm or reject the diagnosis of ruptured membranes is modest in nonlaboring women presenting with nonspecific vaginal fluid loss. Am J Perinatol. 1994 Jan;11(1):46-50.</citation>
    <PMID>8155212</PMID>
  </reference>
  <reference>
    <citation>Jeurgens-Borst AJ, Bekkers RL, Sporken JM, van der Berg PP. Use of insulin like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Eur J Obstet Gynecol Reprod Biol 2002;102:11-14</citation>
  </reference>
  <reference>
    <citation>Watanabe T, Minakami H, Itoi H, Sato I, Sakata Y, Tamada T. Evaluation of latex agglutination test for alpha-fetoprotein in diagnosing rupture of fetal membranes. Gynecol Obstet Invest. 1995;39(1):15-8.</citation>
    <PMID>7534254</PMID>
  </reference>
  <reference>
    <citation>Fujimoto S, Kishida T, Sagawa T, Negishi H, Okuyama K, Hareyama H, Makinoda S. Clinical usefulness of the dye-injection method for diagnosing premature rupture of the membranes in equivocal cases. J Obstet Gynaecol (Tokyo 1995). 1995 Jun;21(3):215-20.</citation>
    <PMID>8590356</PMID>
  </reference>
  <reference>
    <citation>Birkenmaier A, Ries JJ, Kuhle J, Bürki N, Lapaire O, Hösli I. Placental α-microglobulin-1 to detect uncertain rupture of membranes in a European cohort of pregnancies. Arch Gynecol Obstet. 2012 Jan;285(1):21-5. doi: 10.1007/s00404-011-1895-9. Epub 2011 Apr 8.</citation>
    <PMID>21475966</PMID>
  </reference>
  <reference>
    <citation>Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol. 2007 Mar;109(3):634-40.</citation>
    <PMID>17329514</PMID>
  </reference>
  <reference>
    <citation>Eriksen NL, Parisi VM, Daoust S, Flamm B, Garite TJ, Cox SM. Fetal fibronectin: a method for detecting the presence of amniotic fluid. Obstet Gynecol. 1992 Sep;80(3 Pt 1):451-4.</citation>
    <PMID>1495705</PMID>
  </reference>
  <reference>
    <citation>El-Messidi A, Cameron A. Diagnosis of premature rupture of membranes: inspiration from the past and insights for the future. J Obstet Gynaecol Can. 2010 Jun;32(6):561-9. Review.</citation>
    <PMID>20569537</PMID>
  </reference>
  <reference>
    <citation>Hellemans P, Verdonk P, Baekelandt M, Joostens M, Francx M, Gerris J. Preliminary results with the use of the ROM-check immunoassay in the early detection of rupture of the amniotic membranes. Eur J Obstet Gynecol Reprod Biol. 1992 Feb 28;43(3):173-9.</citation>
    <PMID>1563568</PMID>
  </reference>
  <reference>
    <citation>Di Renzo GC, Roura LC, Facchinetti F, Antsaklis A, Breborowicz G, Gratacos E, Husslein P, Lamont R, Mikhailov A, Montenegro N, Radunovic N, Robson M, Robson SC, Sen C, Shennan A, Stamatian F, Ville Y. Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J Matern Fetal Neonatal Med. 2011 May;24(5):659-67. doi: 10.3109/14767058.2011.553694. Epub 2011 Mar 2.</citation>
    <PMID>21366393</PMID>
  </reference>
  <reference>
    <citation>Mariona FG, Cabero L. Are we ready for a new look at the diagnosis of premature rupture of membranes? J Matern Fetal Neonatal Med. 2012 Apr;25(4):403-7. doi: 10.3109/14767058.2011.581715. Epub 2011 Jun 1. Review.</citation>
    <PMID>21627549</PMID>
  </reference>
  <reference>
    <citation>Kurdoglu M, Kolusari A, Adali E, Yildizhan R, Kurdoglu Z, Kucukaydin Z, Kaya A, Kirimi E, Sahin HG, Kamaci M. Does residual amniotic fluid after preterm premature rupture of membranes have an effect on perinatal outcomes? 12 years experience of a tertiary care center. Arch Gynecol Obstet. 2010 Apr;281(4):601-7. doi: 10.1007/s00404-009-1147-4. Epub 2009 Jun 12.</citation>
    <PMID>19521709</PMID>
  </reference>
  <reference>
    <citation>Güngördük K, Asicioglu O, Besimoglu B, Güngördük OC, Yildirm G, Ark C, Sahbaz A. Labor induction in term premature rupture of membranes: comparison between oxytocin and dinoprostone followed 6 hours later by oxytocin. Am J Obstet Gynecol. 2012 Jan;206(1):60.e1-8. doi: 10.1016/j.ajog.2011.07.035. Epub 2011 Jul 30.</citation>
    <PMID>21924396</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 13, 2014</lastchanged_date>
  <firstreceived_date>May 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ROM</keyword>
  <keyword>PROM</keyword>
  <keyword>PPROM (preterm premature rupture of membranes)</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
